HABTE YIMER: Open Payments
NPI 1881666477 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215,550 in 280 payments from 34 companies in 2025. Trend: 2023 $141,512 · 2024 $125,253 · 2025 $215,550
Speaker / faculty: $148,369Consulting: $24,342Travel & lodging: $23,737Honoraria: $11,275Food & beverage: $7,634Education: $193
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 46 | $61,476 |
| Regeneron Healthcare Solutions, Inc. | 38 | $41,293 |
| Janssen Biotech, Inc. | 37 | $30,170 |
| Genmab U.S., Inc. | 23 | $21,778 |
| ABBVIE INC. | 22 | $16,038 |
| ADC THERAPEUTICS AMERICA, INC. | 13 | $12,347 |
| Incyte Corporation | 12 | $7,009 |
| BeOne Medicines USA, Inc. | 3 | $5,974 |
| BeiGene USA, Inc. | 3 | $5,267 |
| PFIZER INC. | 12 | $4,554 |
Products named: IMDELLTRA (AMG757), LYNOZYFIC, EPKINLY, RYBREVANT, ZYNLONTA, BRUKINSA, Monjuvi, KYPROLIS.
Industry payments across TX — which companies pay providers there.
